SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001818382-24-000130
Filing Date
2024-06-17
Accepted
2024-06-17 16:10:42
Documents
2
Period of Report
2024-06-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1718655034.html 3  
1 FORM 3 wk-form3_1718655034.xml 3 1647
2 EX-24 exhibit24-bamforth.htm EX-24 6532
  Complete submission text file 0001818382-24-000130.txt   9724
Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Issuer) CIK: 0001818382 (see all company filings)

IRS No.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 1001 PINEHURST DRIVE CHAPEL HILL NC 27517
Business Address
Bamforth John Philip (Reporting) CIK: 0002026341 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39532 | Film No.: 241048308